New Therapeutic Strategies for Adult Patients With Persistent and Chronic Immune Thrombocytopenia

Download All

Choosing treatment for patients with persistent or chronic ITP is incredibly complex with many factors involved. Take this opportunity to deepen your understanding of current and evolving best practices for the treatment of patients with ITP that has not responded well to initial therapy. 

James B. Bussel, MD
Program Director


In this CME-certified module with accompanying downloadable slideset, expert insights are provided on current diagnostic considerations and treatment options for patients with immune thrombocytopenia.

James B. Bussel, MD
Program Director
Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: January 15, 2019 Expired: No longer available for credit
Provided by the Postgraduate Institute for Medicine
PIM Logo

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Dova Pharmaceuticals, Inc.
Novartis Pharmaceuticals Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings